MENU

BCEL

Stock ticker:

PRICE

CHANGE

CAPITALIZATION

Atreca (BCEL) Ownership - Who owns Atreca?

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

835 Industrial Road

Phone

+1 650 595-2595

Employees

90

Web

https://www.atreca.com

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

3.57M

P/E Ratio

N/A

Total Cash

N/A

Projected Growth

N/A

Total Debt

N/A

Revenue

N/A

Risk (Beta)

1.65

Dividend Yield

N/A

Total Cash/Share

N/A

Total Debt/Equity

N/A

Revenue/Share

null USD as % of share price

View a ticker or compare two or three

VS

VS

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for BCEL

A.I. Advisor

published General Information

General Information

a biopharmaceutical company, which develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response.

Industry Biotechnology

Profile

Details

Industry

N/A

Address

835 Industrial Road

Phone

+1 650 595-2595

Employees

90

Web

https://www.atreca.com